In the special “GENETIC INSTABILITY” of Swiss Oncology in Motion, Prof. Dr. med. Viola Heinzelmann-Schwarz (University Hospital Basel), Prof. Dr. med. Jens Huober (Canton Hospital St. Gallen), PD Dr. med. Aurelius Omlin (OnkoZentrum Zürich), Prof. Dr. med. Dr. phil. Andreas Wicki (University Hospital Zurich) and Prof. Dr. med. Wolfram Jochum (Cantonal Hospital St. Gallen) discussed the role of genetic instability in various tumor types, in particular ovarian and endometrial carcinomas, breast carcionoma, GI tumors, and prostate, urothelial, and renal cell carcinomas, and how it influences treatment options. The discussion will be led by Prof. em. Richard Herrmann, MD, Basel, moderated.
You May Also Like
- Long-COVID
Increased risk with asthma and COPD
- Case report: bronchobiliary fistula
Disguised as pneumonia
- Rehospitalization risk for cardiopulmonary diseases
Transition to the outpatient setting is crucial
- Telemonitoring
Home earlier: sensory T-shirt monitors vital functions
- Ginkgo biloba for mild dementia: new meta-analysis
Improvements in several domains relevant to everyday life
- From symptom to diagnosis
Dyspnea – Lung metastases
- Potential biomarkers for diagnostics, prognosis and therapy
Male infertility
- Artesunate in uro-oncology